M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals

Table 5 Correlations between non-invasive assessment methods at baseline and sustained virologic response 12

Variables		LSM	Serum M2BPGi	FIB-4 score
At baseline
Serum M2BPGi level	r	0.453
	P value	< 0.001b
FIB-4 score	r	0.328	-0.099
	P value	0.003b	0.384
PAPAS index	r	0.110	-0.049	0.444
	P value	0.330	0.664	< 0.001b
At SVR12
Serum M2BPGi level	r	0.517
	P value	< 0.001b
FIB-4 score	r	0.231	0.188
	P value	0.039a	0.095
PAPAS index	r	0.328	0.185	0.188
	P value	0.003b	0.100	0.095

^aP < 0.05.

^bP < 0.01. SVR: Sustained virologic response; LSM: Liver stiffness measurement; M2BPGi: Mac-2 binding protein glycosylation isomer.